Protalix CFO Eyal Rubin resigns; to serve six-month transition through Oct 2025

Protalix BioTherapeutics, Inc.

Eyal Rubin, Sr. VP & CFO, provided six months' notice on April 21, 2025 to pursue other opportunities.
He will continue in his role for the six-month period and assist with transition.
Compensation Committee agreed to full salary, benefits, and equity incentives during the period.
Upon termination, he will receive two months' salary severance and full accelerated vesting of unvested equity.
No successor has been appointed; earlier termination possible with mutual agreement.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Eyal Rubin

Senior Vice President and Chief Financial Officer

PLX · Protalix BioTherapeutics, Inc.

Filed: April 23, 2025, 7:59 PM ET

On April 21, 2025, Eyal Rubin, Sr. Vice President and Chief Financial Officer of Protalix BioTherapeutics, Inc., a Delaware corporation (the “Company”), provided the Company and the Company’s Board of Directors with six months’ notice of his resignation from his position with the Company and its subsidiary, in order to pursue other opportunities.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Eyal Rubin resigned as Senior Vice President and Chief Financial Officer at Protalix BioTherapeutics, Inc..

Action: resigned
Role: Senior Vice President and Chief Financial Officer

Exact text from the filing

On April 21, 2025, Eyal Rubin, Sr. Vice President and Chief Financial Officer of Protalix BioTherapeutics, Inc., a Delaware corporation (the “Company”), provided the Company and the Company’s Board of Directors with six months’ notice of his resignation from his position with the Company and its subsidiary, in order to pursue other opportunities.

View on SEC.gov

Protalix BioTherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-25-005275

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.